nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—Sorafenib—thyroid cancer	0.16	0.307	CbGbCtD
Granisetron—CYP3A4—Vandetanib—thyroid cancer	0.104	0.199	CbGbCtD
Granisetron—CYP2D6—Sorafenib—thyroid cancer	0.0982	0.188	CbGbCtD
Granisetron—CYP3A4—Sorafenib—thyroid cancer	0.0624	0.12	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—thyroid cancer	0.0596	0.114	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—thyroid cancer	0.0379	0.0726	CbGbCtD
Granisetron—Pain—Vandetanib—thyroid cancer	0.00226	0.00473	CcSEcCtD
Granisetron—Constipation—Vandetanib—thyroid cancer	0.00226	0.00473	CcSEcCtD
Granisetron—Arrhythmia—Sorafenib—thyroid cancer	0.00224	0.00469	CcSEcCtD
Granisetron—Alopecia—Sorafenib—thyroid cancer	0.00222	0.00464	CcSEcCtD
Granisetron—Liver injury—Epirubicin—thyroid cancer	0.0022	0.00459	CcSEcCtD
Granisetron—Malnutrition—Sorafenib—thyroid cancer	0.00219	0.00457	CcSEcCtD
Granisetron—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00216	0.00452	CcSEcCtD
Granisetron—Dysgeusia—Sorafenib—thyroid cancer	0.00214	0.00448	CcSEcCtD
Granisetron—Abdominal pain—Vandetanib—thyroid cancer	0.00209	0.00437	CcSEcCtD
Granisetron—Body temperature increased—Vandetanib—thyroid cancer	0.00209	0.00437	CcSEcCtD
Granisetron—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00205	0.00428	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00203	0.00425	CcSEcCtD
Granisetron—Liver injury—Doxorubicin—thyroid cancer	0.00203	0.00425	CcSEcCtD
Granisetron—Anaemia—Sorafenib—thyroid cancer	0.00202	0.00422	CcSEcCtD
Granisetron—Oliguria—Epirubicin—thyroid cancer	0.00201	0.00419	CcSEcCtD
Granisetron—Dyskinesia—Epirubicin—thyroid cancer	0.00197	0.00411	CcSEcCtD
Granisetron—Syncope—Sorafenib—thyroid cancer	0.00196	0.0041	CcSEcCtD
Granisetron—Leukopenia—Sorafenib—thyroid cancer	0.00196	0.00409	CcSEcCtD
Granisetron—Loss of consciousness—Sorafenib—thyroid cancer	0.00192	0.00402	CcSEcCtD
Granisetron—Cough—Sorafenib—thyroid cancer	0.00191	0.00399	CcSEcCtD
Granisetron—Atrioventricular block—Epirubicin—thyroid cancer	0.00191	0.00398	CcSEcCtD
Granisetron—Asthenia—Vandetanib—thyroid cancer	0.0019	0.00397	CcSEcCtD
Granisetron—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00189	0.00396	CcSEcCtD
Granisetron—Hypertension—Sorafenib—thyroid cancer	0.00189	0.00395	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00188	0.00393	CcSEcCtD
Granisetron—Pruritus—Vandetanib—thyroid cancer	0.00187	0.00391	CcSEcCtD
Granisetron—Arthralgia—Sorafenib—thyroid cancer	0.00186	0.00389	CcSEcCtD
Granisetron—Oliguria—Doxorubicin—thyroid cancer	0.00186	0.00388	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00185	0.00386	CcSEcCtD
Granisetron—Hepatocellular injury—Epirubicin—thyroid cancer	0.00185	0.00386	CcSEcCtD
Granisetron—Hiccups—Epirubicin—thyroid cancer	0.00185	0.00386	CcSEcCtD
Granisetron—Dry mouth—Sorafenib—thyroid cancer	0.00182	0.00381	CcSEcCtD
Granisetron—Dyskinesia—Doxorubicin—thyroid cancer	0.00182	0.0038	CcSEcCtD
Granisetron—Diarrhoea—Vandetanib—thyroid cancer	0.00181	0.00378	CcSEcCtD
Granisetron—Melaena—Epirubicin—thyroid cancer	0.00181	0.00377	CcSEcCtD
Granisetron—Anaphylactic shock—Sorafenib—thyroid cancer	0.00178	0.00373	CcSEcCtD
Granisetron—Infection—Sorafenib—thyroid cancer	0.00177	0.00371	CcSEcCtD
Granisetron—Atrioventricular block—Doxorubicin—thyroid cancer	0.00176	0.00369	CcSEcCtD
Granisetron—Shock—Sorafenib—thyroid cancer	0.00176	0.00367	CcSEcCtD
Granisetron—Fluid retention—Epirubicin—thyroid cancer	0.00175	0.00367	CcSEcCtD
Granisetron—Nervous system disorder—Sorafenib—thyroid cancer	0.00175	0.00366	CcSEcCtD
Granisetron—Dizziness—Vandetanib—thyroid cancer	0.00175	0.00366	CcSEcCtD
Granisetron—Thrombocytopenia—Sorafenib—thyroid cancer	0.00175	0.00365	CcSEcCtD
Granisetron—Skin disorder—Sorafenib—thyroid cancer	0.00173	0.00362	CcSEcCtD
Granisetron—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00171	0.00358	CcSEcCtD
Granisetron—Hiccups—Doxorubicin—thyroid cancer	0.00171	0.00358	CcSEcCtD
Granisetron—Coma—Epirubicin—thyroid cancer	0.00169	0.00353	CcSEcCtD
Granisetron—Vomiting—Vandetanib—thyroid cancer	0.00168	0.00352	CcSEcCtD
Granisetron—Melaena—Doxorubicin—thyroid cancer	0.00167	0.00349	CcSEcCtD
Granisetron—Rash—Vandetanib—thyroid cancer	0.00167	0.00349	CcSEcCtD
Granisetron—Dermatitis—Vandetanib—thyroid cancer	0.00167	0.00348	CcSEcCtD
Granisetron—Headache—Vandetanib—thyroid cancer	0.00166	0.00346	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00163	0.0034	CcSEcCtD
Granisetron—Fluid retention—Doxorubicin—thyroid cancer	0.00162	0.00339	CcSEcCtD
Granisetron—Abnormal vision—Epirubicin—thyroid cancer	0.00161	0.00337	CcSEcCtD
Granisetron—Dyspnoea—Sorafenib—thyroid cancer	0.00159	0.00333	CcSEcCtD
Granisetron—Nausea—Vandetanib—thyroid cancer	0.00157	0.00328	CcSEcCtD
Granisetron—Dyspepsia—Sorafenib—thyroid cancer	0.00157	0.00328	CcSEcCtD
Granisetron—Coma—Doxorubicin—thyroid cancer	0.00156	0.00327	CcSEcCtD
Granisetron—Decreased appetite—Sorafenib—thyroid cancer	0.00155	0.00324	CcSEcCtD
Granisetron—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00154	0.00322	CcSEcCtD
Granisetron—Photosensitivity—Epirubicin—thyroid cancer	0.00153	0.00319	CcSEcCtD
Granisetron—Pain—Sorafenib—thyroid cancer	0.00153	0.00319	CcSEcCtD
Granisetron—Constipation—Sorafenib—thyroid cancer	0.00153	0.00319	CcSEcCtD
Granisetron—Abnormal vision—Doxorubicin—thyroid cancer	0.00149	0.00312	CcSEcCtD
Granisetron—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00146	0.00305	CcSEcCtD
Granisetron—Urticaria—Sorafenib—thyroid cancer	0.00142	0.00296	CcSEcCtD
Granisetron—Photosensitivity—Doxorubicin—thyroid cancer	0.00141	0.00296	CcSEcCtD
Granisetron—Abdominal pain—Sorafenib—thyroid cancer	0.00141	0.00295	CcSEcCtD
Granisetron—Body temperature increased—Sorafenib—thyroid cancer	0.00141	0.00295	CcSEcCtD
Granisetron—Hyponatraemia—Epirubicin—thyroid cancer	0.00135	0.00282	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00134	0.00281	CcSEcCtD
Granisetron—Migraine—Epirubicin—thyroid cancer	0.00132	0.00276	CcSEcCtD
Granisetron—Hypersensitivity—Sorafenib—thyroid cancer	0.00131	0.00275	CcSEcCtD
Granisetron—Asthenia—Sorafenib—thyroid cancer	0.00128	0.00268	CcSEcCtD
Granisetron—Pruritus—Sorafenib—thyroid cancer	0.00126	0.00264	CcSEcCtD
Granisetron—Hyponatraemia—Doxorubicin—thyroid cancer	0.00125	0.00261	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00124	0.0026	CcSEcCtD
Granisetron—Liver function test abnormal—Epirubicin—thyroid cancer	0.00124	0.00259	CcSEcCtD
Granisetron—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00123	0.00256	CcSEcCtD
Granisetron—Migraine—Doxorubicin—thyroid cancer	0.00122	0.00255	CcSEcCtD
Granisetron—Hypokalaemia—Epirubicin—thyroid cancer	0.00122	0.00255	CcSEcCtD
Granisetron—Diarrhoea—Sorafenib—thyroid cancer	0.00122	0.00255	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00121	0.00253	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00118	0.00247	CcSEcCtD
Granisetron—Dizziness—Sorafenib—thyroid cancer	0.00118	0.00247	CcSEcCtD
Granisetron—Abdominal distension—Epirubicin—thyroid cancer	0.00117	0.00244	CcSEcCtD
Granisetron—Eosinophilia—Epirubicin—thyroid cancer	0.00115	0.0024	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00115	0.0024	CcSEcCtD
Granisetron—Vomiting—Sorafenib—thyroid cancer	0.00113	0.00237	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00113	0.00237	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—thyroid cancer	0.00113	0.00236	CcSEcCtD
Granisetron—Angina pectoris—Epirubicin—thyroid cancer	0.00113	0.00236	CcSEcCtD
Granisetron—Rash—Sorafenib—thyroid cancer	0.00112	0.00235	CcSEcCtD
Granisetron—Dermatitis—Sorafenib—thyroid cancer	0.00112	0.00235	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00112	0.00234	CcSEcCtD
Granisetron—Headache—Sorafenib—thyroid cancer	0.00112	0.00234	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00109	0.00229	CcSEcCtD
Granisetron—Dysuria—Epirubicin—thyroid cancer	0.00108	0.00227	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—thyroid cancer	0.00108	0.00226	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—thyroid cancer	0.00106	0.00222	CcSEcCtD
Granisetron—Nausea—Sorafenib—thyroid cancer	0.00106	0.00222	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00106	0.00221	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—thyroid cancer	0.00105	0.00219	CcSEcCtD
Granisetron—Jaundice—Epirubicin—thyroid cancer	0.00101	0.00211	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—thyroid cancer	0.001	0.0021	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—thyroid cancer	0.001	0.0021	CcSEcCtD
Granisetron—Sweating—Epirubicin—thyroid cancer	0.000991	0.00207	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000979	0.00205	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000978	0.00204	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—thyroid cancer	0.000975	0.00204	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—thyroid cancer	0.00097	0.00203	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—thyroid cancer	0.000945	0.00198	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—thyroid cancer	0.000932	0.00195	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—thyroid cancer	0.00093	0.00195	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—thyroid cancer	0.00093	0.00194	CcSEcCtD
Granisetron—Sweating—Doxorubicin—thyroid cancer	0.000917	0.00192	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—thyroid cancer	0.000912	0.00191	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000905	0.00189	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—thyroid cancer	0.000902	0.00189	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—thyroid cancer	0.000897	0.00188	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—thyroid cancer	0.000894	0.00187	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—thyroid cancer	0.000874	0.00183	CcSEcCtD
Granisetron—Flushing—Epirubicin—thyroid cancer	0.000861	0.0018	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—thyroid cancer	0.000861	0.0018	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000844	0.00176	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—thyroid cancer	0.000842	0.00176	CcSEcCtD
Granisetron—Chills—Epirubicin—thyroid cancer	0.000833	0.00174	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—thyroid cancer	0.000829	0.00173	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—thyroid cancer	0.000828	0.00173	CcSEcCtD
Granisetron—Alopecia—Epirubicin—thyroid cancer	0.00082	0.00171	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—thyroid cancer	0.000808	0.00169	CcSEcCtD
Granisetron—Flushing—Doxorubicin—thyroid cancer	0.000797	0.00167	CcSEcCtD
Granisetron—Flatulence—Epirubicin—thyroid cancer	0.000796	0.00166	CcSEcCtD
Granisetron—Tension—Epirubicin—thyroid cancer	0.000793	0.00166	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—thyroid cancer	0.000791	0.00165	CcSEcCtD
Granisetron—Nervousness—Epirubicin—thyroid cancer	0.000785	0.00164	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—thyroid cancer	0.000779	0.00163	CcSEcCtD
Granisetron—Chills—Doxorubicin—thyroid cancer	0.000771	0.00161	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—thyroid cancer	0.000767	0.0016	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—thyroid cancer	0.000759	0.00159	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—thyroid cancer	0.00075	0.00157	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—thyroid cancer	0.000748	0.00156	CcSEcCtD
Granisetron—Anaemia—Epirubicin—thyroid cancer	0.000747	0.00156	CcSEcCtD
Granisetron—Agitation—Epirubicin—thyroid cancer	0.000742	0.00155	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—thyroid cancer	0.000737	0.00154	CcSEcCtD
Granisetron—Tension—Doxorubicin—thyroid cancer	0.000734	0.00153	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—thyroid cancer	0.000732	0.00153	CcSEcCtD
Granisetron—Malaise—Epirubicin—thyroid cancer	0.000729	0.00152	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—thyroid cancer	0.000726	0.00152	CcSEcCtD
Granisetron—Vertigo—Epirubicin—thyroid cancer	0.000726	0.00152	CcSEcCtD
Granisetron—Syncope—Epirubicin—thyroid cancer	0.000725	0.00151	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—thyroid cancer	0.000723	0.00151	CcSEcCtD
Granisetron—Palpitations—Epirubicin—thyroid cancer	0.000714	0.00149	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—thyroid cancer	0.00071	0.00148	CcSEcCtD
Granisetron—Cough—Epirubicin—thyroid cancer	0.000705	0.00147	CcSEcCtD
Granisetron—Hypertension—Epirubicin—thyroid cancer	0.000698	0.00146	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000694	0.00145	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—thyroid cancer	0.000691	0.00144	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—thyroid cancer	0.000688	0.00144	CcSEcCtD
Granisetron—Chest pain—Epirubicin—thyroid cancer	0.000688	0.00144	CcSEcCtD
Granisetron—Agitation—Doxorubicin—thyroid cancer	0.000687	0.00144	CcSEcCtD
Granisetron—Anxiety—Epirubicin—thyroid cancer	0.000685	0.00143	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000683	0.00143	CcSEcCtD
Granisetron—Discomfort—Epirubicin—thyroid cancer	0.00068	0.00142	CcSEcCtD
Granisetron—Malaise—Doxorubicin—thyroid cancer	0.000674	0.00141	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—thyroid cancer	0.000673	0.00141	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—thyroid cancer	0.000672	0.0014	CcSEcCtD
Granisetron—Syncope—Doxorubicin—thyroid cancer	0.00067	0.0014	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—thyroid cancer	0.000669	0.0014	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—thyroid cancer	0.000661	0.00138	CcSEcCtD
Granisetron—Oedema—Epirubicin—thyroid cancer	0.000659	0.00138	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—thyroid cancer	0.000659	0.00138	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—thyroid cancer	0.000657	0.00137	CcSEcCtD
Granisetron—Infection—Epirubicin—thyroid cancer	0.000655	0.00137	CcSEcCtD
Granisetron—Cough—Doxorubicin—thyroid cancer	0.000652	0.00136	CcSEcCtD
Granisetron—Shock—Epirubicin—thyroid cancer	0.000649	0.00136	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—thyroid cancer	0.000647	0.00135	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—thyroid cancer	0.000646	0.00135	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—thyroid cancer	0.000645	0.00135	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—thyroid cancer	0.000644	0.00135	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—thyroid cancer	0.00064	0.00134	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—thyroid cancer	0.000637	0.00133	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—thyroid cancer	0.000636	0.00133	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—thyroid cancer	0.000636	0.00133	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—thyroid cancer	0.000634	0.00133	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000632	0.00132	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—thyroid cancer	0.000629	0.00131	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—thyroid cancer	0.000622	0.0013	CcSEcCtD
Granisetron—Hypotension—Epirubicin—thyroid cancer	0.000616	0.00129	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00061	0.00128	CcSEcCtD
Granisetron—Oedema—Doxorubicin—thyroid cancer	0.00061	0.00128	CcSEcCtD
Granisetron—Infection—Doxorubicin—thyroid cancer	0.000606	0.00127	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000601	0.00126	CcSEcCtD
Granisetron—Shock—Doxorubicin—thyroid cancer	0.0006	0.00126	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—thyroid cancer	0.000598	0.00125	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000597	0.00125	CcSEcCtD
Granisetron—Insomnia—Epirubicin—thyroid cancer	0.000596	0.00125	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—thyroid cancer	0.000595	0.00124	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—thyroid cancer	0.000593	0.00124	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—thyroid cancer	0.000592	0.00124	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00059	0.00123	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—thyroid cancer	0.000588	0.00123	CcSEcCtD
Granisetron—Somnolence—Epirubicin—thyroid cancer	0.000586	0.00123	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—thyroid cancer	0.00058	0.00121	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—thyroid cancer	0.000573	0.0012	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—thyroid cancer	0.00057	0.00119	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000569	0.00119	CcSEcCtD
Granisetron—Pain—Epirubicin—thyroid cancer	0.000564	0.00118	CcSEcCtD
Granisetron—Constipation—Epirubicin—thyroid cancer	0.000564	0.00118	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000556	0.00116	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—thyroid cancer	0.000552	0.00115	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—thyroid cancer	0.000548	0.00115	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—thyroid cancer	0.000544	0.00114	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—thyroid cancer	0.000543	0.00114	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—thyroid cancer	0.000542	0.00113	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000539	0.00113	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—thyroid cancer	0.000537	0.00112	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—thyroid cancer	0.00053	0.00111	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000527	0.0011	CcSEcCtD
Granisetron—Urticaria—Epirubicin—thyroid cancer	0.000524	0.0011	CcSEcCtD
Granisetron—Pain—Doxorubicin—thyroid cancer	0.000522	0.00109	CcSEcCtD
Granisetron—Constipation—Doxorubicin—thyroid cancer	0.000522	0.00109	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—thyroid cancer	0.000521	0.00109	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—thyroid cancer	0.000521	0.00109	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—thyroid cancer	0.000503	0.00105	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000499	0.00104	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—thyroid cancer	0.000486	0.00102	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—thyroid cancer	0.000485	0.00101	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—thyroid cancer	0.000482	0.00101	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—thyroid cancer	0.000482	0.00101	CcSEcCtD
Granisetron—Asthenia—Epirubicin—thyroid cancer	0.000473	0.000989	CcSEcCtD
Granisetron—Pruritus—Epirubicin—thyroid cancer	0.000467	0.000975	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—thyroid cancer	0.000451	0.000943	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—thyroid cancer	0.000449	0.00094	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—thyroid cancer	0.000438	0.000915	CcSEcCtD
Granisetron—Dizziness—Epirubicin—thyroid cancer	0.000436	0.000912	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—thyroid cancer	0.000432	0.000903	CcSEcCtD
Granisetron—Vomiting—Epirubicin—thyroid cancer	0.000419	0.000877	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—thyroid cancer	0.000417	0.000873	CcSEcCtD
Granisetron—Rash—Epirubicin—thyroid cancer	0.000416	0.000869	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—thyroid cancer	0.000415	0.000868	CcSEcCtD
Granisetron—Headache—Epirubicin—thyroid cancer	0.000413	0.000864	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—thyroid cancer	0.000403	0.000844	CcSEcCtD
Granisetron—Nausea—Epirubicin—thyroid cancer	0.000392	0.000819	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—thyroid cancer	0.000388	0.000811	CcSEcCtD
Granisetron—Rash—Doxorubicin—thyroid cancer	0.000385	0.000804	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—thyroid cancer	0.000384	0.000804	CcSEcCtD
Granisetron—Headache—Doxorubicin—thyroid cancer	0.000382	0.000799	CcSEcCtD
Granisetron—Nausea—Doxorubicin—thyroid cancer	0.000362	0.000758	CcSEcCtD
